ArticleInternal medicine (Tokyo, Japan)2020

Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin.

Atsushi Isoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.